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The integration of traditional, complementary, and integra-
tive medicine (CIM) in contemporary cancer care is an emer-
gent field of clinical practice and research throughout the
world. The use of herbs, nutrition, mind-body, and spiritual
practices is deeply rooted in the cross-cultural mosaic of
Middle Eastern and South Asian nations. The concept of in-
tegrative oncology has emerged in the last decade to signify
the need to amalgamate traditional and complementary
medicine practices with evidence-based research aiming to
improve supportive cancer care. The integration of ancient
roots with contemporary scientific sprouts is not merely
a metaphor but a significant tool for promoting holistic
patient-centered care that emphasizes patients’ well-being
rather than focusing merely on cancer cells and disease-cen-
tered terminology. Indeed, the remarkable achievements in
contemporary integrative oncology only emphasize the need
for a patient-tailored strategy of care attuned to the individ-
ual’s biophysical, psychological, social, cultural, and spiritual
needs and concerns. The integrative challenge is how to pro-
vide an evidence-based consultation and supportive treat-
ment to patients who confront fear at the moment of break-
ing the bad news of cancer diagnosis; how to improve their
well-being during chemotherapy, radiation, surgical, or pal-
liative treatment; and how to support patients and their care
providers along the survivorship pathway or across the thre-
shold of life. In daily practice, integrative oncology may be
employed to reduce nausea and vomiting (e.g., use of the
traditional Ayurvedic and Chinese herb Zingiber oﬃcinale
known as ginger [1]), to alleviate pain (e.g., acupuncture
[2]), and to improve fatigue (e.g., exercise, relaxation and
body awareness training combined with massage [3]), mood
disturbances (manual modalities [4]), and many other
disease symptoms and chemotherapy side eﬀects. Integrative
oncology is also challenged by the need to obtain CIM safety
(e.g., awareness of the risks of herbal-chemotherapy inter-
actions) and high-quality standards of CIM supplements
as well as professional training of integrative practitioners.
Last but not least, these fundamental elements need to be
enhanced by open communication channels between CIM
practitioners, oncologists, and other health care providers
in order to conclude a comprehensive integrative approach
based on vibrant multidisciplinary discourse. Hence, the
concept of integrative oncology goes far beyond traditional,
alternative, or complementary practice, signifying a call for
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holistic practice, a whole that is larger than the sum of its
scientific, clinical, and humanistic parts.
The paper by H. Zaid et al. featured in this special
issue reviews the concept of traditional Islamic medicine
with regard to herbs with potential anticancer activity.
This paper illuminates the importance of bridging ancient
knowledge rooted in Greco-Arabic medicine and contem-
porary research. But, in addition to the extensive review
presented by H. Zaid et al., this paper is also distinc-
tive thanks to the contribution of the two other authors
in this collaborative Israeli-Palestinian paper. Notable is
the contribution of M. Silbermann, the director of the
US National Cancer Institute-aﬃliated Middle-East Can-
cer Consortium (MECC), who has succeeded over the last
15 years in promoting supportive care collaborations that
have included joint integrative oncology projects between
MECC (Egypt, Israel, Palestinian Authority, Jordan, Turkey,
and Cyprus) and other Middle-Eastern countries [5, 6].
The paper by E. Ben-Arye presents an integrative oncol-
ogy program operated within conventional oncology services
in northern Israel aimed at improving patients’ quality of
life during chemotherapy and advanced cancer. The authors
address barriers to integration of traditional and comple-
mentary medicine in supportive care of Arab patients and
propose six practical recommendations aimed at improving
patients’ access to integrative supportive care as well as com-
pliance with treatments. This paper emphasizes the need to
base integrative oncology on a sensitive cross-cultural ap-
proach that takes into consideration social, cultural, and spi-
ritual elements.
The paper by M. Schaltz et al. intensifies this cross-cul-
tural theme by reflecting on palliative care from the perspec-
tive of Jewish and Islamic traditions. The collaboration in
this paper between M. Schultz and K. Baddarni, two scholars
in spiritual supportive care in northern Israel, highlights the
richness of therapeutic dialogue between Muslim and Jewish
health care providers who share faith in the role of the inte-
grative dialogue. This paper summarizes ethical, religious,
and spiritual insights gleaned in the management of patients
in the community-centered Al-Taj organization and in the
oncology department in Rambam health care campus, which
is named for the renowned Jewish physician Maimonides.
The paper authored by I. Cantarero-Villanueva et al.
from Granada presents the flavor of the ancient cities of
southern Spain, the backdrop for the Golden Age of collabo-
rative Muslim and Jewish physicians, including Maimonides
and the followers of Ibn-Sina, the most prominent Islamic
medicine scholar. In this paper, the authors evaluated, in a
randomized controlled trial, the eﬀects of a multimodal exer-
cise and massage program on the well-being of breast cancer
survivors. The reduced fatigue, tension, depression, and
improved vigor and muscle strength after intervention and 6
months after discharge are remarkable and support the need
for other rigorous trials in the integrative oncology field.
Moving from West to East across the Mediterranean and
West Asia, the paper by P. Puataweeponge et al. presents the
notion of complementary medicine in Bangkok, Thailand.
The authors present a study regarding CAM use by a large
cohort of cancer patients attending outpatient radiotherapy
treatment in Thailand. The high prevalence of CAM use of
more than 60% is notable in light of the patient-oncologist
communication gap illustrated by the high prevalence
(58.3%) of patients who did not disclose CAM use to their
doctors. This communication aspect should raise concern
when 9.4% of patients in this study reported side eﬀects of
CAM treatments. Moreover, this study emphasizes the need
for a paradigm shift from CAM (with emphasis on alterna-
tive) to CIM (with emphasis on integrative) that will enable
patients and physicians to discuss complementary use in an
open nonjudgmental context.
Two papers in this issue present the fundamental in vitro
research elements needed to base any clinical integrative on-
cology activity. Zhang et al. from China report. the anti-
cancer eﬀects of the photochemical Zerumbone, isolated
from the plant Zingiber zerumbet Smith. Although addition-
al rigorous studies are warranted, the promising apoptosis
induction eﬀect of this plant on pancreatic carcinoma cell
lines may suggest that ginger and related plants may have
anticancer properties in addition to their beneficial eﬀect in
chemotherapy-related nausea and vomiting. In the paper by
Y. H. Liu et al. from neighboring Taiwan, they studied Abrin,
a protein purified from the seeds of Abrus precatorius, and
reported that prohibitin, a tumor-suppressing protein, plays
a role in abrin-induced apoptosis. These findings join the
growing number of promising studies in integrative onco-
logy that may support development of new and, in some
cases, traditional medicine-based, therapeutic agents and
modalities for the benefit of patients with cancer across the
globe.
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